Gallant Custom Laboratories

What Gallant Custom Laboratories does

Gallant Custom Laboratories Inc. is a Canadian autogenous veterinary biologics manufacturer operating from a single CFIA-licensed facility at 1425 Bishop St. N, Units 10-13, Cambridge, Ontario. Founded in 1995 and acquired by Ceva Animal Health in July 2019 as part of Ceva's purchase of the IDT Animal Health Division, the company produces killed bacterins, viral vaccines, and toxoids manufactured from pathogens isolated directly from sick animals on customer farms. Its product portfolio is organized by livestock species — porcine, bovine, avian, and ovine/caprine — plus an autogenous Swine Influenza Virus vaccine, each targeting multi-serotype pathogens that commercial licensed vaccines do not adequately cover. The company also operates an in-house diagnostic testing laboratory offering real-time PCR, bacteriology with serotyping and susceptibility testing, and virus isolation, which both serves external veterinarians and feeds the isolate workflow underpinning custom production.

The business operates under a prescription-only regulatory model: products are sold exclusively through licensed veterinarians, who direct isolate submission, prescribe the autogenous product, and act as the regulatory gatekeeper required by CFIA rules. Pricing is quote-based, varying with the number of doses ordered and the number of antigens included, with bottling available in 5 mL, 30 mL, 100 mL, and 500 mL sizes. Use is geographically restricted to the site of isolate origin unless shared-risk justification applies, and the market served is Canada only. Marketing is minimal, relying on a website with downloadable technical resources, an email newsletter, and direct relationships through the veterinarian channel. Customer service, accounting, and careers are administered through Ceva Canada, indicating operational integration under the parent.

Name

Gallant Custom Laboratories

Legal name

Gallant Custom Laboratories Inc.

Website

https://gallantcustomlaboratories.com

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

11–50 employees

Short description

Gallant Custom Laboratories is a CFIA-licensed Canadian manufacturer of autogenous veterinary bacterins, viral vaccines, and toxoids, plus diagnostic testing, serving licensed veterinarians who prescribe custom farm-specific biologics for swine, bovine, avian, and small-ruminant producers across Canada.

Ownership category

akta.pro rank

Product category

Veterinary biologics manufacturing

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Medical Laboratories (621511)

SIC

Biological Products, (No Disgnostic Substances) (2836), Services-Testing Laboratories (8734)

akta.pro primary industry

Autogenous (Herd-Specific) Vaccines (HLAMAKAF)

akta.pro secondary industries

Veterinary Vaccines (Biologics) (HLAMAEAL), Veterinary Microbiology & Infectious Disease Testing (Culture/PCR/Serology) (HLAMADAC), Veterinary Pharmacy, Vaccine & Biologics Services (AFAEANAK)

Keywords

• Autogenous veterinary biologics
• Livestock bacterins manufacturing
• Custom animal vaccines
• Veterinary diagnostic testing
• CFIA licensed biologics

Headquarters

HQ city

Cambridge

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Autogenous Bacterins and Vaccines: Custom autogenous veterinary biologics including bacterins (killed bacterial vaccines), viral vaccines, and toxoids. Products are sold only through licensed veterinarians as prescription products. Revenue is generated through product sales with pricing based on number of doses and number of antigens included.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Gallant Custom Laboratories manufactures custom autogenous veterinary biologics — bacterins, viral vaccines, and toxoids — produced from pathogens isolated directly from the customer's herd or flock, targeting specific pathogenic organisms and serotypes not covered by commercial vaccines. Products are prescription veterinary biologics regulated by the Canadian Food Inspection Agency (CFIA) and are sold only through licensed veterinarians for use on the originating site. The company also operates an in-house diagnostic testing laboratory providing real-time PCR, bacteriology, serotyping, Mycoplasma screening, and virus isolation services.

Product overview

Gallant Custom Laboratories is a single-product veterinary biologics company offering autogenous veterinary biologics (bacterins, vaccines, and toxoids) for livestock. The core offering consists of species-specific autogenous bacterins for Bovine (cattle), Avian (poultry), Ovine/Caprine (sheep/goats), and Porcine (swine) animals, plus a Swine Influenza Virus (SIV) autogenous vaccine. These products are manufactured from pathogens isolated directly from the customer's herd or flock, providing a customizable alternative when licensed commercial products are unavailable or do not cover circulating strains. The company also operates an in-house diagnostic testing laboratory providing bacteriology, virology, PCR testing, and serotyping services. Supporting services include specimen submission forms, safety data sheets, and multiple bottling solution sizes. All products require a licensed veterinarian to prescribe and are regulated by the Canadian Food Inspection Agency (CFIA).

Differentiator

Problem solved

Functional benefit

Products and services

• Autogenous Biologics (Bacterins, Vaccines, and Toxoids) Custom autogenous veterinary biologics including bacterins, vaccines, and toxoids manufactured from pathogens isolated directly from sick animals on farms. These are customizable products targeted at specific pathogenic organisms and serotypes present in a herd or flock, offered when licensed commercial products are unavailable or do not cover current strains. Sold only through licensed veterinarians as prescription products.
• Bovine Autogenous Bacterins Autogenous bacterins for cattle targeting Escherichia coli (neonatal scours and mastitis), Salmonella species, Clostridium perfringens type A, Klebsiella, Staphylococcus aureus, Citrobacter (mastitis), Moraxella bovis/bovoculi (Pink eye), and Mycoplasma bovis.
• Avian Autogenous Bacterins Autogenous bacterins for poultry (turkeys, ducks, geese, chickens) targeting Pasteurella multocida (Fowl Cholera), Erysipelothrix rhusiopathiae, Ornithobacterium rhinotracheale (ORT), Riemerella anatipestifer (New Duck Disease), Salmonella species, Escherichia coli, and Clostridium perfringens.
• Ovine and Caprine Autogenous Bacterins Autogenous bacterins for sheep and goats targeting Corynebacterium pseudotuberculosis (caseous lymphadenitis/CL).
• Porcine Autogenous Bacterins Autogenous bacterins for swine targeting Haemophilus parasuis (Glasser's disease), Streptococcus suis, Actinobacillus suis, Actinobacillus pleuropneumoniae, Erysipelothrix rhusiopathiae, Escherichia coli (neonatal/post-weaning scours and oedema disease), Clostridium perfringens/difficile (neonatal scours), Staphylococcus hyicus (greasy pig disease), and Mycoplasma hyosynoviae/hyorhinis.
• Swine Influenza Virus (SIV) Autogenous Vaccine Autogenous vaccine for Swine Influenza Virus manufactured using a certified cell line tested for extraneous viruses, bacteria, fungi, and Mycoplasma. Includes virus isolation from herd, CFIA approval, and serological testing for antibody titres.
• Diagnostic Testing Laboratory Services Comprehensive specimen testing including bacteriology (isolation, identification, serotyping, susceptibility testing, aerobic/anaerobic cultures), virology (SIV identification by Real-Time PCR and tissue culture isolation), Mycoplasma screening and isolation, and virotyping for pathogenic Escherichia coli (ETEC and ExPEC).

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Ceva Animal HealthcoreStrategic or Co-development Partner · 3 July 2019Gallant Custom Laboratories Inc. is a Ceva Animal Health company. Ceva completed acquisition of IDT Animal Health Division in July 2019. Gallant operates as part of the Ceva Animal Health portfolio of veterinary biologics companies, with shared resources including customer service (Ceva Customer Service Commercial), accounting inquiries through Ceva, and careers information available through Ceva Canada Careers page.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• HIPRA: HIPRA is a Spanish animal health company with a strong autogenous vaccine portfolio across swine and ruminants, providing comparable herd-specific bacterins and vaccines to European and global livestock producers.
• Vaxxinova: Vaxxinova is one of the leading global specialists in autogenous vaccines for livestock and aquaculture, serving swine, poultry, and ruminant producers with farm-specific biologics in direct competition with Gallant's offering.
• Cambridge Technologies: Cambridge Technologies is a US-based autogenous biologics manufacturer specializing in custom vaccines for swine and cattle, sharing Gallant's exact business model of farm-isolated pathogen bacterins.
• Phibro Animal Health: Phibro operates a large autogenous vaccine business through its Animal Health division, directly competing with Gallant in herd-specific bacterins and custom biologics for livestock pathogens across multiple species.
• Deltamune: Deltamune manufactures autogenous vaccines and diagnostics for livestock producers in North America, with overlapping species coverage (swine, poultry, ruminants) directly comparable to Gallant's product range.

Broad incumbents

• Merck Animal Health: Merck Animal Health (MSD Animal Health) provides a broad range of commercial livestock vaccines and health products, including swine influenza and Mycoplasma vaccines that overlap with Gallant's autogenous indications.
• Elanco Animal Health: Elanco is a major global animal health player offering commercial livestock vaccines and pharmaceuticals, representing the broader competitive context in which Gallant's niche autogenous biologics operate.
• Ceva Animal Health: Ceva is the global animal health parent company that acquired Gallant Custom Laboratories via the 2019 IDT Animal Health acquisition; it operates a broad portfolio of vaccines, pharmaceuticals, and equipment across companion and production animals.
• Zoetis: Zoetis is the largest global animal health company with a comprehensive livestock vaccine and diagnostics portfolio, including commercial vaccines that compete with Gallant's autogenous offerings for the same pathogen indications.
• Boehringer Ingelheim Animal Health: Boehringer Ingelheim is a global animal health leader with extensive livestock vaccine offerings, particularly in swine and poultry, representing the broad incumbent competitive set against which Gallant's autogenous biologics compete.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gallant Custom Laboratories